Gout

Therapeutic challenges in the management of gout in the elderly
Gout is the most common inflammatory arthritis in the elderly population.

Little Rock, AR
USA
Debunking the myths to provide 21st Century management of gout
Epidemiologic and recent qualitative research suggests that the impact of under-treated gout is far more significant than many health professionals realise.
Private Bag 94052, South Auckland Mail Centre
Manukau City, New Zealand
New Zealand
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised
BACKGROUND: Non-steroidal anti-inflammatory drugs and colchicine used to treat gout arthritis have gastrointestinal, renal, and cardiovascular adverse effects.

Nijmegen, the Netherlands
The Netherlands
Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast deve
OBJECTIVE: To analyze cellular mechanisms of bone erosion in gout.

Auckland, New Zealand
New Zealand
Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly h
BACKGROUND: Physical activity and cardiorespiratory fitness are not currently recognized as factors related to preventing gout, nor are risk factors for gout in physically active men well understood.

Berkeley, CA 94720
USA
Hyperuricaemia—where nephrology meets rheumatology
Rheumatologists care for patients with gouty arthritis, a condition caused by chronic and uncontrolled hyperuricaemia.

Pittsburgh, PA
USA
Gout and related morbid conditions: pharmacological and SPA therapy
Gouty arthritis is estimated to be the most frequent manifestation of inflammatory arthritis in men aged over 40.

Rome, Italy
Italy
Systemic corticosteroids for acute gout
BACKGROUND: Gout is one of the most frequently occurring rheumatic diseases, worldwide.


USA
Efficacy and tolerability of urate lowering drugs in gout: a randomised controlled trial of benzbrom
OBJECTIVES: To investigate the efficacy and tolerability of allopurinol as first-choice antihyperuricemic treatment for gout, and compare the efficacy and tolerability of benzbromarone and probenecid as second-choice treatment.

Groningen, The Netherlands
The Netherlands
Refractory gout: what is it and what to do about it?
PURPOSE OF REVIEW: The purpose of this review is to discuss the defining characteristics of refractory gout and the pharmacological management of this problem.

Durham, NC 27710
USA